EcoDrugPlus

Aurora Kinase A

Ensembl ID : ENSCDRG00005017220
Gene Symbol: AURKA
3 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSCDRG00005014394
Gene Symbol: AURKB
3 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSCDRG00005013041
Gene Symbol: AURKC
1 Cross references
99 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSCDRG00005018468
Gene Symbol: BACE1
3 Cross references
220 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSCDRG00005001772
Gene Symbol: BDKRB1
3 Cross references
149 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSCDRG00005001759
Gene Symbol: BDKRB2
3 Cross references
362 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSCDRG00005003673
Gene Symbol: BCHE
1 Cross references
130 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSCDRG00005009544
Gene Symbol: CALCRL
1 Cross references
149 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSCDRG00005007236
Gene Symbol: CASR
1 Cross references
203 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1

Ensembl ID : ENSCDRG00005019330
Gene Symbol: CACNA2D1
1 Cross references
287 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2

Ensembl ID : ENSCDRG00005009520
Gene Symbol: CACNA2D2
1 Cross references
269 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 3

Ensembl ID : ENSCDRG00005015242
Gene Symbol: CACNA2D3
3 Cross references
213 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).